Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest From Inpharmatica Ltd.


ADMETRx is building new and improved ADME tools. The technology, a mix of wet lab analysis and computer modeling, attempts to move beyond the go/no go decisions typical of ADME.Instead the company offers clients a ranking of a drugs being tested based on the individual properties being tested.


Recent Dealmaking (07/2004)

Summarizing the month in European dealmaking.

Recent Dealmaking (7/2003)

Summarizing the month in European dealmaking.

Waltzing with Bears

Biotechs raising series C and D rounds, even those which have made their technology or commercial milestones, are finding that VCs aren't willing to give them a step-up in valuation from their previous round of financing. For management, the situation means more dilution, but VCs, even those who paid up in previous rounds, like the new prices, in part because they're confident that the IPO market will return soon.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
      • Bioinformatics
      • Genomics-Proteomics